Schedule 13G ownership disclosure

INOVIO PHARMACEUTICALS INC

Common Stock · CUSIP: 45773H409

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • JANUS HENDERSON GROUP PLC

    Shares: 3,266,260 · Class: 6.2%

  • Janus Henderson Biotech Innovation Master Fund Ltd

    Shares: 2,802,530 · Class: 5.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-25-000276
Form type
SCHEDULE 13G
Filer
INOVIO PHARMACEUTICALS, INC.
CIK
CIK 1055726
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub